SCHEMBL76792

SCHEMBL76792

CSc1ccc(C)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL27813433 0.97 MEN1 (0.54) —
Hydrochloric Acid SCHEMBL7990919 0.97 MEN1 (0.54) —
SCHEMBL25723788 0.91 MEN1 (0.50) —
SCHEMBL19110965 0.91 MAPT (0.50) —
SCHEMBL8736741 0.91 MEN1 (0.50) —
SCHEMBL406210 0.91 MAPT (0.50) —
Alcohol SCHEMBL28988327 0.87 MAPT (0.52) —
SCHEMBL83839 0.86 ALDH1A1 (0.58) —
SCHEMBL18533141 0.84 CYP1A1 (0.61) —
SCHEMBL407203 0.84 TEAD4 (0.54) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3545 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072741-A1 PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-04-03 — — WO claimed
CN-111320560-B Method for preparing sulfoxide compound by photocatalytic oxidation of thioether in aqueous phase 南阳师范学院 2022-06-24 — — CN claimed
US-10224485-B2 Process for preparing a crystalline organic semiconductor material BASF SE (DE) 2019-03-05 — — US claimed
EP-2585069-A1 PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN Janssen Pharmaceutica, N.V. (BE) 2013-05-01 — — EP claimed
EP-1973886-B1 PROKINETICIN 1 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2013-02-27 — — EP claimed
WO-2012006004-A1 PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN JANSSEN PHARMACEUTICA NV (BE) 2012-01-12 — — WO claimed
US-20110319400-A1 PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN JANSSEN PHARMACEUTICA, NV (BE) 2011-12-29 — — US claimed
EP-2385042-A1 Prokineticin 1 receptor antagonists Janssen Pharmaceutica N.V. (BE) 2011-11-09 — — EP claimed
US-8039028-B2 Use of an extract of the orchid Vanda coerulea as a skin hydrating agent LVMH REACHERCHE (FR) 2011-10-18 — — US claimed
US-7902358-B2 Gastrointestinal disorders; inflammatory bowel disorders; gastroesophageal reflux, constipation; diarrhea JANSSEN PHARMACEUTICA NV (BE) 2011-03-08 — — US claimed
US-5900512-A PROCESS CONTROL USING BROMINE CHLORINE SOLUTIONS ALBEMARLE CORPORATION (US) 1999-05-04 — — US claimed
WO-1998058979-A1 POLYUREA POLYURETHANE ELASTOMERS WITH HIGH TEMPERATURE RESISTANCE AND/OR FLAME-RETARDANT AND/OR EXCELLENT RESISTANCE TO HYDROLYSIS GANGA ROLAND (FR) 1998-12-30 — — WO claimed
EP-0880504-A1 HETEROCYCLO-SUBSTITUTED IMIDAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE &amp; CO. (US) 1998-12-02 — — EP claimed
US-5750510-A ANTIBIOTICS ABBOTT LABORATORIES (US) 1998-05-12 — — US claimed
WO-1997042205-A1 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES ABBOTT LABORATORIES (US) 1997-11-13 — — WO claimed
WO-1997027181-A1 HETEROCYCLO-SUBSTITUTED IMIDAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-07-31 — — WO claimed
EP-0772600-A1 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE &amp; CO. (US) 1997-05-14 — — EP claimed
US-5616601-A 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation GD SEARLE & CO (US) 1997-04-01 — — US claimed
US-5508180-A OXIDATION OF SULFIDES; DEALKYLATION OF ETHERS, AMINES; HALOGENATION; POLYMERIZATION ENZYMOL INTERNATIONAL, INC. 1996-04-16 — — US claimed
WO-1996003388-A1 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 — — WO claimed
Send feedback